Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.28 +0.09 (+0.45%)
As of: Oct 22, 2026 · 11:07 AM EDT

Acadia Pharmaceuticals (ACAD) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Acadia Pharmaceuticals' Depreciation & Amortization (CF) came in at $434,000 for Q2 2026, up 103.8% from $213,000 a year earlier and up 60.1% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Acadia Pharmaceuticals reported Depreciation & Amortization (CF) of $1.16 million, up 30.1% year-over-year; for FY2025, it was $900,000, down 2.2% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last four years, with a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $920,000 in FY2024 (-38.7%), $1.5 million in FY2023 (-26.0%), $2.03 million in FY2022 (-9.4%) and $2.24 million in FY2021 (+49.1%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) since Q4 2022.
  • Year-over-year, Depreciation & Amortization (CF) has increased for four consecutive quarters, with growth averaging 6.1% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2026 (growth of 103.8%), and the weakest in Q2 2024 (a decline of 43.8%).
  • Business Quant data shows ACAD's Depreciation & Amortization (CF) at $271,000 (Q1 2026), $231,000 (Q4 2025) and $227,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,172.05 Bn 1,140.63 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 636.25 Bn 554.77 Bn 17.26 Bn 1.96 Bn
3 AbbVie 503.38 Bn 476.49 Bn 12.70 Bn 194.00 Mn
4 Merck 377.92 Bn 332.30 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 304.19 Bn 268.18 Bn 11.24 Bn -
6 Astrazeneca 267.24 Bn 240.93 Bn 12.86 Bn 1.93 Bn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 193.78 Bn 167.97 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn 1.62 Bn
10 Acadia Pharmaceuticals 3.48 Bn 1.18 Mn 279.64 Mn 434,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 434,000.00
Mar 31, 2026 271,000.00
Dec 31, 2025 231,000.00
Sep 30, 2025 227,000.00
Jun 30, 2025 213,000.00
Mar 31, 2025 229,000.00
Dec 31, 2024 226,000.00
Sep 30, 2024 226,000.00
Jun 30, 2024 226,000.00
Mar 31, 2024 242,000.00
Dec 31, 2023 313,000.00
Sep 30, 2023 359,000.00
Jun 30, 2023 402,000.00
Mar 31, 2023 426,000.00
Dec 31, 2022 489,000.00
Sep 30, 2022 506,000.00
Jun 30, 2022 515,000.00
Mar 31, 2022 516,000.00
Dec 31, 2021 535,000.00
Sep 30, 2021 616,000.00
API Access

Acadia Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ACAD&period=max&api_key=YOUR_API_KEY